Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions.
暂无分享,去创建一个
Dirk Grosenick | Rainer Macdonald | Herbert Rinneberg | Axel Hagen | Peter M Schlag | Alexander Poellinger | P. Schlag | R. Macdonald | H. Rinneberg | D. Grosenick | A. Poellinger | A. Hagen | S. Burock | P. Warnick | Susen Burock | Peter Warnick
[1] H. Rinneberg,et al. Detection and characterization of breast tumours by time-domain scanning optical mammography , 2008 .
[2] D. Boas,et al. Dynamic functional and mechanical response of breast tissue to compression. , 2008, Optics express.
[3] B. Chance,et al. Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods , 2008, Physics in medicine and biology.
[4] E. Uzgiris. Tumor Microvasculature: Endothelial Leakiness and Endothelial Pore Size Distribution in a Breast Cancer Model , 2008, Breast cancer : basic and clinical research.
[5] B. Tromberg,et al. Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. , 2007, Journal of biomedical optics.
[6] M. Schweiger,et al. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. , 2007, Optics express.
[7] Jennifer J. Gibson,et al. Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. , 2007, Radiology.
[8] B. Tromberg,et al. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy , 2007, Proceedings of the National Academy of Sciences.
[9] O. Steinkellner,et al. Development of a multi-channel time-domain fluorescence mammograph , 2007, SPIE BiOS.
[10] Ruth Duncan,et al. Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.
[11] B. Tromberg,et al. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. , 2006, Journal of biomedical optics.
[12] Hamid Dehghani,et al. Image analysis methods for diffuse optical tomography. , 2006, Journal of biomedical optics.
[13] M. Dewhirst,et al. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.
[14] K. T. Moesta,et al. Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas , 2005, Physics in medicine and biology.
[15] K. T. Moesta,et al. Time-domain scanning optical mammography: I. Recording and assessment of mammograms of 154 patients , 2005, Physics in medicine and biology.
[16] Alessandro Torricelli,et al. Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions , 2005, Physics in medicine and biology.
[17] Peter Hauff,et al. Comparison of Two Tricarbocyanine-Based Dyes for Fluorescence Optical Imaging , 2005, Journal of Fluorescence.
[18] R. Lucht,et al. Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.
[19] Heidrun Wabnitz,et al. Four-wavelength multichannel time-resolved optical mammograph , 2003, European Conference on Biomedical Optics.
[20] Heidrun Wabnitz,et al. A four-wavelength multi-channel scanning time-resolved optical mammograph , 2003 .
[21] J. Ripoll,et al. In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. , 2003, Medical physics.
[22] Anthony J. Durkin,et al. In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. , 2003, Applied optics.
[23] Robert C. Brasch,et al. Macromolecular contrast agents for MR mammography: current status , 2003, European Radiology.
[24] H. Dvorak,et al. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor‐associated microvessels in man and animals , 2002, Microscopy research and technique.
[25] P. Vaupel,et al. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. , 2000, International journal of oncology.
[26] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[27] Eva M. Sevick-Muraca,et al. Pharmacokinetics of ICG and HPPH-car for the Detection of Normal and Tumor Tissue Using Fluorescence, Near-infrared Reflectance Imaging: A Case Study¶ , 2000, Photochemistry and photobiology.
[28] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[29] V. Ntziachristos,et al. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Colak,et al. Clinical optical tomography and NIR spectroscopy for breast cancer detection , 1999 .
[31] P M Schlag,et al. Development of a time-domain optical mammograph and first in vivo applications. , 1999, Applied optics.
[32] D M Shames,et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. , 1998, AJR. American journal of roentgenology.
[33] Josephine,et al. Binding properties of indocyanine green in human blood. , 1998, Investigative ophthalmology & visual science.
[34] P. Ott,et al. Nontraditional effects of protein binding and hematocrit on uptake of indocyanine green by perfused rat liver. , 1997, The American journal of physiology.
[35] P M Schlag,et al. Frequency-domain techniques enhance optical mammography: initial clinical results. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Ott,et al. The kinetics of continuously infused indocyanine green in the pig , 1996, Journal of Pharmacokinetics and Biopharmaceutics.
[37] A A Lammertsma,et al. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. , 1992, Cancer research.
[38] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[39] N. Ishibashi,et al. Determination of protein in human serum by high-performance liquid chromatography with semiconductor laser fluorometric detection. , 1986, Analytical chemistry.
[40] D. Meijer,et al. Pharmacokinetics of biliary excretion in man V , 1983, European Journal of Clinical Pharmacology.
[41] J. Hodges,et al. Red cell, plasma, and blood volume in the healthy women measured by radiochromium cell-labeling and hematocrit. , 1962, The Journal of clinical investigation.
[42] D. Meijer,et al. Pharmacokinetics of biliary excretion in man. VI. Indocyanine green , 2004, European Journal of Clinical Pharmacology.
[43] B. Pogue,et al. Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results. , 2003, Applied optics.
[44] D Artemov,et al. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. , 2001, Neoplasia.
[45] P S Tofts,et al. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. , 1994, Magnetic resonance imaging.
[46] P. Ott,et al. Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures. , 1993, Journal of hepatology.